Last updated on June 2018

A clinical trial sponsored by Novo Nordisk A/S for a research study of semaglutide, placebo

Brief description of study

This trial is conducted globally. The aim of this trial is to investigate efficacy and safety of oral semaglutide versus placebo in subjects with type 2 diabetes and moderate renal impairment.

Clinical Study Identifier: NCT02827708

Contact Investigators or Research Sites near you

Start Over

Novo Nordisk Investigational Site
Belgorod, Russian Federation